Robert Thomas Dechant - 26 Feb 2025 Form 4 Insider Report for IBEX Ltd (IBEX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Feb 2025, 16:54:14 UTC
Prior SEC filing
14 Feb 2025
Next SEC filing
16 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Lisa Lenstrohm, Attorney-in-Fact

Key filing fact

Robert Thomas Dechant filed Form 4 for IBEX Ltd (IBEX) on 27 Feb 2025.

Key facts

  • This page summarizes Robert Thomas Dechant's Form 4 filing for IBEX Ltd (IBEX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Feb 2025, 16:54.

Change

  • Previous filing in this sequence was filed on 14 Feb 2025.
  • Current net transaction value: -$673,569.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBEX transaction

Common Shares

Options Exercise

Transaction value
$636,620
Shares
+49,931
Change %
+23%
Price
$12.75
Shares after
263,564
Date
26 Feb 2025
Ownership
Direct
IBEX transaction

Common Shares

Sale

Transaction value
$1,310,189
Shares
-49,931
Change %
-19%
Price
$26.24
Shares after
213,633
Date
26 Feb 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IBEX transaction Derivative

Stock Option (Right to Buy Common Shares)

Options Exercise

Transaction value
$0
Shares
-49,931
Change %
-100%
Price
$0.000000
Shares after
69
Date
26 Feb 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
49,931
Exercise price
$12.75
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option are fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .